Cigall Kadoch

Cigall Kadoch is an accomplished researcher in the field of Pediatric Oncology, currently serving as an Associate Professor at Dana-Farber Cancer Institute since January 2014, and previously as an Assistant Professor in the same department. Additionally, Cigall Kadoch is a Scientific Founder and member of the Board of Directors at Foghorn Therapeutics, Inc., while also holding the title of Institute Member at the Broad Institute. Prior experience includes a postdoctoral fellowship and a graduate student role at Stanford University School of Medicine, where a Ph.D. in Cancer Biology was conferred. Earlier positions include a Staff Research Associate at UCSF and a Lab Assistant during undergraduate studies at the UCSF Diabetes Center. Educational qualifications include a B.A. in Molecular and Cell Biology with Honors from the University of California, Berkeley.